<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>DARU Journal of Pharmaceutical Sciences</JournalTitle><Volume>12</Volume><Issue>3</Issue></Journal><ArticleTitle>"Preparation, biodistribution and stability of [65zn]bleomycin complex "</ArticleTitle><FirstPage>115</FirstPage><LastPage>122</LastPage><AuthorList><Author><FirstName></FirstName><LastName>Amir Reza Jalilian</LastName></Author><Author><FirstName></FirstName><LastName>Pejman Rowshanfarzad</LastName></Author><Author><FirstName></FirstName><LastName>Ali Rahiminejad-Kisomi</LastName></Author><Author><FirstName></FirstName><LastName>Sedigheh Moradkhani</LastName></Author><Author><FirstName></FirstName><LastName>Farahnaz Motamedi-Sedeh</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>06</Day></PubDate></History><Abstract>Bleomycin (BLM) has been labeled with various radioisotopes and widely used in therapy and diagnosis. In this study BLM was labeled with [65Zn] zinc chloride and its distribution and stability in normal and tumor bearing mice was determined. The complex was obtained at the pH=2 in normal saline at 90 °C in 60 minutes. Radio-TLC showed an overall radiochemical yield of 95-97% (radiochemical purity &gt;97%).
The in vitro stability of the complex was determined in mice and human plasma. Preliminary studies were performed to determine distribution of [65Zn]BLM in normal and tumor bearing mice on the basis of these results. [65Zn]BLM may be used in therapeutic studies due to its suitable physico-chemical properties.</Abstract><web_url>https://daru.tums.ac.ir/index.php/daru/article/view/213</web_url><pdf_url>https://daru.tums.ac.ir/index.php/daru/article/download/213/213</pdf_url></Article></Articles>
